{"title":"战略联盟或并购是制药公司的创新之路?","authors":"Lars Schweizer","doi":"10.4172/2169-026X.1000116","DOIUrl":null,"url":null,"abstract":"Biotechnology and pharmaceutical are one of the strongest growing industries of the twenty-first century. Since the inception of Genentech – which is often referred to as the first modern biotechnology firm – in 1976, many thousands of new biotechnology ventures have been founded, and some of these ventures have been extraordinarily successful [1]. For example, Genentech’s market capitalization was $100 billion in 2012, and the firm employed more than 11,000 people.","PeriodicalId":433140,"journal":{"name":"Journal of Entrepreneurship & Organization Management","volume":"23 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2014-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Strategic Alliances or M & A as the Road to Innovation for PharmaceuticalCompanies?\",\"authors\":\"Lars Schweizer\",\"doi\":\"10.4172/2169-026X.1000116\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Biotechnology and pharmaceutical are one of the strongest growing industries of the twenty-first century. Since the inception of Genentech – which is often referred to as the first modern biotechnology firm – in 1976, many thousands of new biotechnology ventures have been founded, and some of these ventures have been extraordinarily successful [1]. For example, Genentech’s market capitalization was $100 billion in 2012, and the firm employed more than 11,000 people.\",\"PeriodicalId\":433140,\"journal\":{\"name\":\"Journal of Entrepreneurship & Organization Management\",\"volume\":\"23 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Entrepreneurship & Organization Management\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/2169-026X.1000116\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Entrepreneurship & Organization Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2169-026X.1000116","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Strategic Alliances or M & A as the Road to Innovation for PharmaceuticalCompanies?
Biotechnology and pharmaceutical are one of the strongest growing industries of the twenty-first century. Since the inception of Genentech – which is often referred to as the first modern biotechnology firm – in 1976, many thousands of new biotechnology ventures have been founded, and some of these ventures have been extraordinarily successful [1]. For example, Genentech’s market capitalization was $100 billion in 2012, and the firm employed more than 11,000 people.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
